黄酒多酚诱导沉默调节蛋白3表达减轻阿霉素心肌损伤研究

doi:10.12114/j.issn.1007-9572.2022.01.605

中国全科医学 ›› 2022, Vol. 25 ›› Issue (17): 2102-2109.DOI: 10.12114/j.issn.1007-9572.2022.01.605

所属专题：心血管最新文章合集

黄酒多酚诱导沉默调节蛋白3表达减轻阿霉素心肌损伤研究

孙世民¹, 孙珍珠², 池菊芳³, 郭航远¹^,⁴^,^*()

1.325000　浙江省温州市，温州医科大学第一临床医学院
2.318000　浙江省台州市，台州医院心血管内科
3.312000　浙江省绍兴市人民医院心内科
4.312000　浙江省绍兴市文理学院

收稿日期:2022-02-06 修回日期:2022-04-06 出版日期:2022-04-28 发布日期:2022-04-28
通讯作者: 郭航远
孙世民，孙珍珠，池菊芳，等.黄酒多酚诱导沉默调节蛋白3表达减轻阿霉素心肌损伤研究[J].中国全科医学，2022，25（17）：2102-2109.[www.chinagp.net]
作者贡献：孙世民设计研究方案，进行细胞实验及后期数据收集、统计学分析，绘制图表等；孙珍珠负责进行动物实验中的造模、取材以及切片染色；池菊芳负责文章的质量控制及审校；郭航远提出研究思路，对文章整体负责、监督管理。
基金资助:
国家自然科学基金面上项目(81873120); 绍兴市人民医院院内青年基金项目(2018YB24)

Yellow Wine Polyphenolic Compounds Regulate SIRT3 Expression to Alleviate Doxorubicin-induced Myocardial Injury

Shimin SUN¹, Zhenzhu SUN², Jufang CHI³, Hangyuan GUO¹^,⁴^,^*()

1.The First School of Medicine, Wenzhou Medical University, Wenzhou 325000, China
2.Cardiovascular Department, Taizhou Hospital of Zhejiang Province, Taizhou 318000, China
3.Department of Cardiology, Shaoxing People's Hospital, Shaoxing 312000, China
4.Shaoxing University, Shaoxing 312000, China

Received:2022-02-06 Revised:2022-04-06 Published:2022-04-28 Online:2022-04-28
Contact: Hangyuan GUO
About author:
SUN S M, SUN Z Z, CHI J F, et al. Yellow Wine Polyphenolic Compounds regulate SIRT3 expression to alleviate doxorubicin-induced myocardial injury[J]. Chinese General Practice, 2022, 25 (17) : 2102-2109.

分享到

摘要/Abstract

摘要： 背景阿霉素（DOX）是一种常见的强效蒽环类抗肿瘤药物，被广泛应用于各类肿瘤尤其是实体性肿瘤的治疗中。然而，DOX有较强的心脏毒性，临床表现为不可逆性心肌病和充血性心力衰竭。黄酒多酚（YWPC）是从绍兴黄酒中提取的多酚类物质，具有抗炎、抗氧化等生理活性，对DOX所致心肌损伤有一定缓解作用，但其作用机制还不明晰。目的通过体内外实验探讨YWPC减轻DOX心肌损伤的作用机制。方法动物实验：使用SD大鼠建立DOX心肌损伤模型，分为对照组、YWPC组、DOX组与DOX+YWPC组；取心脏组织进行MASSON染色、原位末端标记（TUNEL）染色及免疫组织化学染色，取血清测定乳酸脱氢酶（LDH）水平，并用动物组织蛋白、Western Blot法检测凋亡水平〔B淋巴细胞瘤-2蛋白（Bcl-2）、Bcl-2相关X蛋白（Bax）〕及沉默调节蛋白3（SIRT3）表达水平变化。体外实验：通过1 μmol/L DOX干预H9C2细胞24 h建立DOX诱导H9C2细胞损伤模型，先将一批H9C2细胞分为对照组、DOX组、DOX+YWPC（1 mg/L）组、DOX+YWPC（10 mg/L）与DOX+YWPC（100 mg/L）5组，采用CCK-8法检测H9C2细胞活力，通过Western Blot法检测凋亡水平及SIRT3表达水平变化；之后将另一批H9C2细胞分为对照组、DOX组、DOX+YWPC组、DOX+SIRT3抑制剂（3-TYP）组及DOX+YWPC+3-TYP组，通过3-TYP抑制SIRT3蛋白活性，通过Western Blot法检测凋亡水平及SIRT3表达水平变化，进一步明确SIRT3在YWPC减轻DOX心肌损伤中的作用。结果动物实验中，大鼠心肌切片通过MASSON染色后可见：DOX组大鼠心肌纤维排列紊乱，大量蓝色胶原纤维贯穿心肌纤维；DOX+YWPC组大鼠心肌切片纹理部分恢复，蓝色胶原纤维减少。DOX组胶原纤维占比、血清LDH水平高于对照组、DOX+YWPC组（P<0.05）。DOX组Bcl-2/Bax比值、SIRT3表达水平低于对照组、DOX+YWPC组（P<0.05）；DOX组大鼠心肌切片中代表凋亡的绿色亮点明显增多，呈片状分布，而经YWPC治疗后凋亡亮点减少。体外实验中，DOX组吸光度值、Bcl-2/Bax比值、SIRT3表达水平低于对照组、DOX+YWPC（1 mg/L）组、DOX+YWPC（10 mg/L）组、DOX+YWPC（100 mg/L）组（P<0.05），DOX组、DOX+3-TYP组Bcl-2/Bax比值、SIRT3表达水平低于对照组（P<0.05）；DOX+YWPC+3-TYP组Bcl-2/Bax比值低于DOX+YWPC组（P<0.05），DOX+YWPC组与DOX+YWPC+3-TYP组SIRT3表达水平比较，差异无统计学意义（P>0.05）。结论 YWPC可以通过调节SIRT3表达水平减轻DOX心肌损伤，抑制SIRT3会降低YWPC的作用。

关键词: 心脏病, 阿霉素, 黄酒多酚, 抗肿瘤药, 沉默调节蛋白3, 细胞凋亡

Abstract:

Background

Doxorubicin (DOX) , a common and powerful anthracycline antitumor agent, has been widely used in the treatment of various tumors, especially solid tumors. However, its strong cardiotoxicity-induced irreversible cardiomyopathy and congestive heart failure limit its clinical application. Yellow Wine Polyphenols Compounds (YWPC) are polyphenols extracted from Shaoxing yellow rice wine which have anti-inflammatory and antioxidant activities, and can alleviate DOX-induced myocardial injury, but the mechanism of actions is still unclear.

Objective

To explore the mechanism of YWPC reducing DOX-induced myocardial injury via in vitro and in vivo experiments.

Methods

SD rats were used for an in vivo experiment and divided into four groups: control group (intervened with normal saline) , YWPC group (intervened with YWPC and normal saline) , DOX group (intervened with DOX and normal saline for establishing a DOX-induced myocardial injury model) and DOX+YWPC group (intervened with DOX, YWPC and normal saline for observing the myocardial protective effect of YWPC in a DOX-induced myocardial injury model) . When the experiment ended, all rats were sacrificed and cardiac tissues were taken out for examining myocardial fiber morphology using Masson's trichrome staining, myocardial cell apoptosis using TUNEL assay, pathological changes using immunohistochemical assay, and levels of proteins (Bcl-2 and Bax) involved in apoptosis as well as expression level of SIRT3 using Western blotting. And the serum lactate dehydrogenase (LDH) was also measured. Cardiomyocyte H9C2 cells of rats were used for an in vitro experiment and divided into five groups: control group, YWPC group (intervened with YWPC and normal saline) , DOX group (intervened with DOX for establishing a DOX-induced myocardial injury model within 24 hours) and three DOX+YWPC (1 mg/L, 10 mg/L, 100 mg/L) groups〔first intervened with DOX for establishing a DOX-induced myocardial injury model within 24 hours, then with YWPC for observing the myocardial protective effect of three concentrations of YWPC (1 mg/L, 10 mg/L, 100 mg/L) , respectively〕. Viability of H9C2 cells was measured by CCK-8 assay. Apoptosis, and SIRT3 expressed in H9C2 cells were measured by Western blotting. Then another batch of the same H9C2 cells were took and divided into control group, DOX group, DOX+YWPC group, DOX+3-TYP group and DOX+YWPC+3-TYP group, and SIRT3 inhibitor 3-TYP was used to inhibit the activity of SIRT3 protein in the latter two groups. Then apoptosis level and SIRT3 protein expressed in H9C2 cells were detected by Western blotting for further assessing the effect of SIRT3 in reducing DOX-induced myocardial injury.

Results

In vivo experiment: (1) Under the microscope, Masson's trichrome-stained myocardial fibers of rats in DOX group were disordered and intersected with a large number of blue collagen fibers. The myocardial texture of DOX+YWPC group was partially restored with decreased blue collagen fibers. DOX group had higher proportion of collagen fibers distributed in cardiovascular tissues, and higher serum LDH than control and DOX+YWPC groups (P<0.05) . DOX group had lower ratio of Bcl-2/Bax and level of expression of SIRT3 than control and DOX+YWPC groups (P<0.05) . The apoptotic myocardial cells with a patch distribution appearing as bright green dots were significantly increased in DOX group at first, but were decreased after YWPC treatment. In vitro experiment: (1) The absorbance value, Bcl-2/Bax ratio and expression level of SIRT3 in DOX group were lower than those of control group, DOX+YWPC (1 mg/L) group, DOX+YWPC (10 mg/L) group and DOX+YWPC (100 mg/L) group (P<0.05) . (2) The Bcl-2 /Bax ratio and expression level of SIRT3 in DOX or DOX+3-TYP group were lower than those in control group (P<0.05) . (3) The Bcl-2/Bax ratio in DOX+YWPC+3-TYP group was lower than that in DOX+YWPC group (P<0.05) . (4) The expression level of SIRT3 was similar in DOX+YWPC and DOX+YWPC+3-TYP groups (P>0.05) .

Conclusion

DOX-induced myocardial injury in in vitro and in vivo experiments with rats may be alleviated by YWPC via improving the expression level of SIRT3, and the effect may be reduced if the expression level of SIRT3 protein is inhibited.

Key words: Heart diseases, Doxorubicin, Yellow Wine Polyphenol Compounds, Antineoplastic agents, SIRT3, Apoptosis

孙世民,孙珍珠,池菊芳,等. 黄酒多酚诱导沉默调节蛋白3表达减轻阿霉素心肌损伤研究[J]. 中国全科医学, 2022, 25(17): 2102-2109. DOI: 10.12114/j.issn.1007-9572.2022.01.605.
Shimin SUN,Zhenzhu SUN,Jufang CHI, et al. Yellow Wine Polyphenolic Compounds Regulate SIRT3 Expression to Alleviate Doxorubicin-induced Myocardial Injury[J]. Chinese General Practice, 2022, 25(17): 2102-2109. DOI: 10.12114/j.issn.1007-9572.2022.01.605.

图/表 8

图1 YWPC缓解DOX引起的大鼠心肌细胞损伤注：大鼠心肌切片Masson染色（×200）结果，YWPC=黄酒多酚，DOX=阿霉素

Figure 1 Effect of YWPC in alleviating DOX-induced myocardial injury in the in vivo experiment with four groups of rats

表1 大鼠心肌损伤相关各实验结果（±s）

Table 1 Results of YWPC in alleviating DOX-induced myocardial injury explored in the in vivo experiment with four groups of rats

组别	只数	胶原纤维占比（%）	LDH（U/L）	Bcl-2/Bax比值	SIRT3表达水平
对照组	6	25.74±0.79^a	3 773.79±201.61^a	1.04±0.10^a	0.99±0.08^a
YWPC组	6	24.73±3.31	4 059.88±35.08	0.90±0.06	0.84±0.05
DOX组	6	38.50±1.19	5 546.91±137.37	0.19±0.01	0.29±0.08
DOX+YWPC组	6	31.68±1.13^a	4 491.68±149.93^a	0.57±0.02^a	0.53±0.04^a
F值		67.76	174.3	244.0	139.7
P值		<0.01	<0.01	<0.01	<0.01

图2 YWPC缓解DOX引起的大鼠心肌细胞凋亡情况注：A为大鼠心肌凋亡相关蛋白表达的变化；B为大鼠心肌切片TUNEL染色结果（×200）；Bcl-2=B淋巴细胞瘤-2蛋白，Bax=Bcl-2相关X蛋白

Figure 2 Effect of YWPC in alleviating myocardial cell apoptosis due to DOX-induced myocardial injury explored in the in vivo experiment with four groups of rats

图3 YWPC缓解DOX引起的H9C2细胞凋亡相关蛋白表达情况

Figure 3 Effect of YWPC in alleviating apoptosis in DOX-injured H9C2 cells explored in the in vitro experiment

表2 H9C2细胞CCK-8及Western Blot法检测结果（±s，n=3）

Table 2 Results of viability measured by CCK-8 assay，and levels of apoptosis and SIRT3 measured by Western blotting in DOX-injured H9C2 cells

组别	吸光度值	Bcl-2/Bax比值	SIRT3表达水平
对照组	1.93±0.01^a	1.08±0.09^a	1.11±0.18^a
DOX组	0.74±0.03	0.08±0.01	0.47±0.05
DOX+YWPC（1 mg/L）组	0.94±0.04^a	0.27±0.02^a	0.89±0.08^a
DOX+YWPC（10 mg/L）组	1.11±0.05^a	0.30±0.05^a	0.91±0.10^a
DOX+YWPC（100 mg/L）组	1.35±0.02^a	0.50±0.01^a	0.95±0.25^a
F值	605.1	256.2	8.142
P值	<0.01	<0.01	0.004

图4 大鼠心脏组织、H9C2细胞内SIRT3表达情况注：A为心肌沉默调节蛋白3（SIRT3）表达水平改变；B为H9C2细胞内SIRT3表达水平改变；C为大鼠心肌切片SIRT3免疫组化染色（×200）

Figure 4 Expression levels of SIRT3 in DOX-injured myocardial tissues of rat model and DOX-injured H9C2 cell model

图5 3-TYP作用下H9C2细胞内凋亡相关蛋白表达及SIRT3表达水平

Figure 5 Expression levels of apoptosis-related proteins and SIRT3 in DOX-injured H9C2 cells intervened with 3-TYP

表3 3-TYP作用下H9C2细胞内凋亡相关蛋白表达及SIRT3表达水平变化（±s，n=3）

Table 3 Changes of expression levels of apoptosis-related protein and SIRT3 in DOX-injured H9C2 cells intervened with 3-TYP

组别	Bcl-2/Bax比值	SIRT3表达水平
对照组	1.06±0.18	1.03±0.08
DOX组	0.15±0.01^a	0.53±0.09^a
DOX+YWPC组	0.56±0.02	0.81±0.03
DOX+3-TYP组	0.14±0.01^a	0.40±0.16^a
DOX+YWPC+3-TYP组	0.08±0.01^b	0.63±0.23
F值	401.6	9.979
P值	<0.01	0.0016

参考文献 24

[1]	DOLINSKY V W. The role of sirtuins in mitochondrial function and doxorubicin-induced cardiac dysfunction[J]. Biol Chem，2017，398（9）：955-974. DOI：10.1515/hsz-2016-0316.
[2]	TAN V Z Z，CHAN N M，ANG W L，et al. Cardiotoxicity after anthracycline chemotherapy for childhood cancer in a multiethnic Asian population[J]. Front Pediatr，2021，9：639603. DOI：10.3389/fped.2021.639603.
[3]	SCULLY R E，LIPSHULTZ S E. Anthracycline cardiotoxicity in long-term survivors of childhood cancer[J]. Cardiovasc Toxicol，2007，7（2）：122-128. DOI：10.1007/s12012-007-0006-4.
[4]	RUSSO M，DELLA SALA A，TOCCHETTI C G，et al. Metabolic aspects of anthracycline cardiotoxicity[J]. Curr Treat Options Oncol，2021，22（2）：18. DOI：10.1007/s11864-020-00812-1.
[5]	林辉，倪婷娟，张杰，等. 黄酒多酚减轻DOX心脏毒性的初步研究[J]. 中国病理生理杂志，2018，34（12）：2132-2138. DOI：10.3969/j.issn.1000-4718.2018.12.004.
[6]	LIN H，ZHANG J，NI T J，et al. Yellow Wine Polyphenolic Compounds prevents Doxorubicin-induced cardiotoxicity through activation of the Nrf2 signalling pathway[J]. J Cell Mol Med，2019，23（9）：6034-6047. DOI：10.1111/jcmm.14466.
[7]	HE L，LIU F X，LI J X. Mitochondrial sirtuins and doxorubicin-induced cardiotoxicity[J]. Cardiovasc Toxicol，2021，21（3）：179-191. DOI：10.1007/s12012-020-09626-x.
[8]	李兵. 丹参多酚酸盐对过氧化氢所致心肌细胞线粒体损伤保护作用的研究[J]. 心脑血管病防治，2021，21（5）：445-450. DOI：10.3969/j.issn.1009-816x.2021.05.008.
[9]	熊琪，周梅，田香，等. 茶多酚对PM2.5诱导的大鼠肺泡巨噬细胞凋亡的抑制作用[J]. 中国现代应用药学，2021，38（19）：2337-2345. DOI：10.13748/j.cnki.issn1007-7693.2021.19.001.
[10]	JUNG M H，JUNG J I，PARK S M，et al. A case of reversible but highly vulnerable adriamycin-induced cardiomyopathy：a multi-modality imaging approach[J]. J Cardiovasc Imaging，2019，27（2）：156-157. DOI：10.4250/jcvi.2019.27.e15.
[11]	VEJPONGSA P，YEH E T H. Prevention of anthracycline-induced cardiotoxicity：challenges and opportunities[J]. J Am Coll Cardiol，2014，64（9）：938-945. DOI：10.1016/j.jacc.2014.06.1167.
[12]	SAWYER D B，PENG X Y，CHEN B，et al. Mechanisms of anthracycline cardiac injury：can we identify strategies for cardioprotection?[J]. Prog Cardiovasc Dis，2010，53（2）：105-113. DOI：10.1016/j.pcad.2010.06.007.
[13]	SAWICKI K T，SALA V，PREVER L，et al. Preventing and treating anthracycline cardiotoxicity：new insights[J]. Annu Rev Pharmacol Toxicol，2021，61：309-332. DOI：10.1146/annurev-pharmtox-030620-104842.
[14]	YARMOHAMMADI F，REZAEE R，KARIMI G. Natural compounds against doxorubicin-induced cardiotoxicity：a review on the involvement of Nrf2/ARE signaling pathway[J]. Phytother Res，2021，35（3）：1163-1175. DOI：10.1002/ptr.6882.
[15]	BAST A，HAENEN G R M M，BRUYNZEEL A M E，et al. Protection by flavonoids against anthracycline cardiotoxicity：from chemistry to clinical trials[J]. Cardiovasc Toxicol，2007，7（2）：154-159. DOI：10.1007/s12012-007-0018-0.
[16]	SHABALALA S，MULLER C J F，LOUW J，et al. Polyphenols，autophagy and doxorubicin-induced cardiotoxicity[J]. Life Sci，2017，180：160-170. DOI：10.1016/j.lfs.2017.05.003.
[17]	林辉，张杰，孟立平，等. 多酚类物质对抗DOX诱导的心肌毒性研究进展[J]. 中国医师杂志，2018，20（3）：474-477. DOI：10.3760/cma.j.issn.1008-1372.2018.03.049.
[18]	SHAKERI A，ZIRAK M R，HAYES A W，et al. Curcumin and its analogues protect from endoplasmic reticulum stress：mechanisms and pathways[J]. Pharmacol Res，2019，146：104335. DOI：10.1016/j.phrs.2019.104335.
[19]	SERGAZY S，SHULGAU Z，FEDOTOVSKIKH G，et al. Cardioprotective effect of grape polyphenol extract against doxorubicin induced cardiotoxicity[J]. Sci Rep，2020，10（1）：14720. DOI：10.1038/s41598-020-71827-9.
[20]	潘孙雷，林辉，骆杭琪，等. 黄酒多酚对糖尿病心肌病大鼠心肌细胞凋亡的影响[J]. 中国应用生理学杂志，2017，33（5）：431-435. DOI：10.12047/j.cjap.5553.2017.104.
[21]	刘龙斌，孟立平，季政，等. 黄酒多酚对同型半胱氨酸诱导的血管平滑肌细胞增殖和迁移的影响及其机制研究[J]. 中国全科医学，2016，19（14）：1676-1683. DOI：10.3969/j.issn.1007-9572.2016.14.015.
[22]	邬秋德，郭航远，孟立平，等. 黄酒多酚抑制同型半胱氨酸诱导的大鼠主动脉血管平滑肌细胞表型转化[J]. 心脑血管病防治，2016，16（2）：104-108. DOI：10.3969/j.issn.1009-816x.2016.02.08.
[23]	YANG N，MA H Y，JIANG Z，et al. Dosing depending on SIRT3 activity attenuates doxorubicin-induced cardiotoxicity via elevated tolerance against mitochondrial dysfunction and oxidative stress[J]. Biochem Biophys Res Commun，2019，517（1）：111-117. DOI：10.1016/j.bbrc.2019.07.029.
[24]	SALEH M F，ELSAYAD M E，GODA A E. Mitigation of doxorubicin-induced cardiotoxicity by dichloroacetate：potential roles of restoration of PGC-1α/SIRT3 signaling and suppression of oxidative stress and apoptosis[J]. Eur Rev Med Pharmacol Sci，2021，25（21）：6573-6584. DOI：10.26355/eurrev_202111_27100.

黄酒多酚诱导沉默调节蛋白3表达减轻阿霉素心肌损伤研究

Yellow Wine Polyphenolic Compounds Regulate SIRT3 Expression to Alleviate Doxorubicin-induced Myocardial Injury

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表 8

参考文献 24

相关文章 15

编辑推荐

Metrics

留言

[1]	高扬, 王贇霞, 张优, 高传玉. ≤45岁急性冠脉综合征患者中超高危冠状动脉粥样硬化性心脏病人群降脂治疗后血脂达标率及影响因素研究[J]. 中国全科医学, 2023, 26(27): 3383-3387.
[2]	张笃飞, 陈仁伟, 莫泽来, 羊玲, 王亚洲, 王海凡. 海南省新生儿先天性心脏病筛查-诊断-评估适宜技术的应用研究[J]. 中国全科医学, 2023, 26(25): 3170-3177.
[3]	任园园, 程功, 蒋红英, 王依阳, 陈亮, 赵慧, 梁宸源. 冠心病患者冠状动脉钙化及其严重程度的影响因素研究[J]. 中国全科医学, 2023, 26(24): 2980-2985.
[4]	夏毓娴, 傅丽娟, 罗雯懿, 沈笑怡, 倪平. 复杂先天性心脏病姑息术后患儿家庭管理水平类型及其影响因素研究[J]. 中国全科医学, 2023, 26(16): 1995-2003.
[5]	陈润霖, 何土凤, 陶俐均, 覃玲巧, 张大成, 章一帆, 赵敏, 钟秋安. 心血管危险因素对颈动脉内中膜进展的影响研究[J]. 中国全科医学, 2023, 26(14): 1709-1715.
[6]	秦长瑜, 陈梅香, 阮征, 徐琳. 冠心病合并血液恶性肿瘤患者全因死亡的危险因素研究[J]. 中国全科医学, 2022, 25(33): 4130-4138,4152.
[7]	耿同会, 李涵, 靳晶晶, 程美娟, 张胜雷, 白亚玲, 徐金升. 抗肿瘤药物相关肾损害患者的临床病理特点分析[J]. 中国全科医学, 2022, 25(33): 4153-4158,4167.
[8]	王玉洁, 王健, 周静威. 清热消癥方对糖尿病肾病大鼠肾损伤的保护作用研究[J]. 中国全科医学, 2022, 25(29): 3678-3685.
[9]	李科, 李征, 耿惠, 马婕. CD38单克隆抗体治疗多发性骨髓瘤疗效和安全性的Meta分析[J]. 中国全科医学, 2022, 25(21): 2661-2669.
[10]	潘婷, 孙铁英. 抗肿瘤药物诱导的机化性肺炎的研究进展[J]. 中国全科医学, 2022, 25(14): 1772-1778.
[11]	丁志敏, 苏凯奇, 高静, 陈婷玉, 冯一璇, 冯晓东. 线粒体功能障碍与脑卒中后抑郁的关系研究进展[J]. 中国全科医学, 2022, 25(12): 1528-1532.
[12]	杨蕾伊, 林桑, 谢其冰, 尹耕. 抗肿瘤PD-1和PD-L1治疗现状与免疫相关不良反应的机制探索[J]. 中国全科医学, 2022, 25(11): 1393-1398.
[13]	韩超，尹洪娜，杨稀瑞，范苗苗，李惠航，王明振，韩其琛，孙忠人. 艾灸对压疮大鼠皮肤损伤修复及PI3K/Akt信号通路的影响[J]. 中国全科医学, 2020, 23(21): 2682-2688.
[14]	张军. 妊娠合并心脏病的多学科（分层）管理[J]. 中国全科医学, 2019, 22(3): 247-252.
[15]	谌海燕，丁晓庆. 薯蓣皂苷对耐三苯氧胺乳腺癌细胞生长的影响研究[J]. 中国全科医学, 2019, 22(29): 3570-3575.